Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr 1;4(2):186-93.
doi: 10.3978/j.issn.2072-1439.2012.01.12.

Pleural infection-current diagnosis and management

Affiliations

Pleural infection-current diagnosis and management

Andrew Rosenstengel. J Thorac Dis. .

Abstract

Pleural infection is a common and increasing clinical problem in thoracic medicine, resulting in significant morbidity and mortality. In recent years there has been a marked increase in interests and publications relating to evolving interventions and management options for pleural infection and empyema. Recently published research data as well as guidelines have suggested better approaches of radiological assessment, updated management algorithms for pleural infection, intrapleural adjunct therapies and re-examined the roles of biomarkers, pleural drainage techniques, and the role of surgery. This review highlights some of the recent advances and recommendations relevant to clinical care of pleural infection.

Keywords: Pleural effusion; disease management; empyema; infection.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest.

Figures

Figure 1
Figure 1
Ultrasound of a patient presenting with Right Middle Lobe pneumonia. Pleural ultrasound can differentiate the consolidated lung (in hepatization phase - white arrow) from adjacent small parapneumonic effusion (arrowhead).
Figure 2
Figure 2
A: This patient presented with a pneumococcal pneumonia which was complicated by pleural infection. A small bore tube was inserted but drainage was limited by extensive septations within the effusion. The patient remained febrile with elevated inflammatory markers; B: Intrapleural tPA and DNase was administered twice daily for three days with dramatic clearance of the loculated effusion. Her fever and inflammatory markers settled and was discharged on antibiotics; C: CXR at 3 months after discharge, with marked improvement of pleural opacities.

References

    1. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980;69:507-512 - PubMed
    1. Brims FJ, Lansley SM, Waterer GW, Lee YC. Empyema thoracis: new insights into an old disease. Eur Respir Rev. 2010;19:220-228 - PMC - PubMed
    1. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518-526 - PubMed
    1. Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM. 1996;89:285-289 - PubMed
    1. Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med. 1999;160:1682-1687 - PubMed